跳至主要内容
临床试验/JPRN-UMIN000015229
JPRN-UMIN000015229已完成未知

Open-label, randomized, controlled study peginterferon alpa-2b plus dose-escalation of ribavirin in patients with chronic hepatitis C - Randomized study evaluating dose-escalation of combination therapy in chronic hepatitis C patients

Okayama University Hospital0 个研究点目标入组 380 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Hemoglobin values at entry visit less than 12 g/dL 2. Allergic to interferon or vaccine preparations 3. Allergic to ribavirin or other nucleos(t)ide preparations 4. Pregnant or under breast feeding 5. Uncontrolled cardiovascular diseases 6. Abnormal hemoglobinemia 7. Chronic renal failure or creatinine clearance value less than 50 mL/min 8. Neurologic or psychiatric disease 9. Sever or decompensated liver disease 10. Hypertension or diabetes 11. History of apoplexy 12. Autoimmune hepatitis 13. Chronic hepatitis B or excessive daily intake of alcohol 14. Concomitant immunosuppressive or herbal medication such as Sho-saiko-to 15. Other conditions considered inappropriate by attending physician

研究者

相似试验

Open-label, randomized, controlled study... | 临床试验